Developing early and improved diagnostic tests to lift ovarian cancer survival rates are the focus of two research projects commencing at The University of Queensland.
UQ scientists Associate Professor Paul Thomas and Professors John Hooper and Trent Munro, will test a new agent measuring its suitability in fighting epithelial ovarian cancer (EOC), in the first study of its kind in humans.
Comments